OptimizeRx Corp — Director's Dealing 2025

May 19, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2025-05-15

Reporting Person: Silvestro Stephen L (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-05-15	Common Stock	A	46948	—	Acquired	168262	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-05-15	Stock Option	$10.65	A	80884	Acquired	2029-05-15	Common Stock (80884)	Direct

Footnotes

F1: Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on May 15, 2026, which is the first anniversary of the date of grant.

F2: The stock option vests in three equal annual installments beginning May 15, 2026, the first anniversary of the grant date.